| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5656294 |
Colonic delivery of drugs |
Aug. 12, 1997 |
| 5648350 |
Dihydrotestosterone for use in androgenotherapy |
Jul. 15, 1997 |
| 5646136 |
Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
Jul. 8, 1997 |
| 5643884 |
Lupane triterpenoid derivatives |
Jul. 1, 1997 |
| 5643604 |
Parenteral dosage form |
Jul. 1, 1997 |
| 5637310 |
Method of treating prostatic adenocarcinoma |
Jun. 10, 1997 |
| 5635498 |
Method of controlling male fertility |
Jun. 3, 1997 |
| RE35517 |
Method, compositions, and compounds for modulating brain excitability |
May. 20, 1997 |
| 5629295 |
Steroidal glycosides for treating hypercholesterolemia |
May. 13, 1997 |
| 5622944 |
Testosterone prodrugs for improved drug delivery |
Apr. 22, 1997 |
| 5620921 |
Ocular androgen therapy in sjogren's syndrome |
Apr. 15, 1997 |
| 5616574 |
Steroid sulphatase inhibitors |
Apr. 1, 1997 |
| 5616573 |
Glucocorticoids |
Apr. 1, 1997 |
| 5604215 |
Steroid sulphatase inhibitors |
Feb. 18, 1997 |
| 5595985 |
Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
Jan. 21, 1997 |
| 5591732 |
Medicament for influencing the degree of activation of the central nervous system |
Jan. 7, 1997 |
| 5591736 |
Method of retarding the progression of chronic renal failure |
Jan. 7, 1997 |
| 5591733 |
Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
Jan. 7, 1997 |
| 5587368 |
Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury |
Dec. 24, 1996 |
| 5587369 |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
Dec. 24, 1996 |
| 5583129 |
Composition for contraception |
Dec. 10, 1996 |
| 5578589 |
Method for suppressing an immunoresponse with an estradiol derivative-chlorambucil conjugate |
Nov. 26, 1996 |
| 5576309 |
Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition |
Nov. 19, 1996 |
| 5574022 |
Method of attenuating physical damage to the spinal cord |
Nov. 12, 1996 |
| 5571795 |
Derivative-compound-conjugates and pharmaceutical compositions comprising same |
Nov. 5, 1996 |
| 5565443 |
Subcutaneous implants based on normegestrol derivatives |
Oct. 15, 1996 |
| 5565444 |
Osteogenesis promoter and osteoporosis remedy |
Oct. 15, 1996 |
| 5563131 |
Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
Oct. 8, 1996 |
| 5562910 |
Vaccine compositions and method for enhancing an immune response |
Oct. 8, 1996 |
| 5556847 |
Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors |
Sep. 17, 1996 |
| 5552394 |
Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
Sep. 3, 1996 |
| 5550120 |
Regulating neuropeptide hormone secretion |
Aug. 27, 1996 |
| 5545635 |
Inhibiting bone loss with equilenin |
Aug. 13, 1996 |
| 5532230 |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
Jul. 2, 1996 |
| 5527789 |
Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof |
Jun. 18, 1996 |
| 5527788 |
Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent |
Jun. 18, 1996 |
| 5525349 |
Compositions and methods for treating the cornea inconjunction with laser irradiation |
Jun. 11, 1996 |
| H1551 |
Topical composition and method for reducing hair loss from human scalp |
Jun. 4, 1996 |
| 5523298 |
Progestationally active 19,11-bridged 4-estrenes |
Jun. 4, 1996 |
| 5521168 |
Estrogen metabolites for lowering intraocular pressure |
May. 28, 1996 |
| 5518725 |
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
May. 21, 1996 |
| 5512557 |
Coronary heart disease treated with 17.beta.oestradiol |
Apr. 30, 1996 |
| 5510341 |
Ovulation-inhibiting preparation for hormonal contraception |
Apr. 23, 1996 |
| 5506220 |
Anti-glaucomatous pharmaceutical composition and the process for obtaining them |
Apr. 9, 1996 |
| 5506221 |
Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents |
Apr. 9, 1996 |
| 5506223 |
.DELTA.5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
Apr. 9, 1996 |
| 5504074 |
Estrogenic compounds as anti-angiogenic agents |
Apr. 2, 1996 |
| 5502044 |
Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
Mar. 26, 1996 |
| 5496556 |
Method of treating prostatic adenocarcinoma |
Mar. 5, 1996 |
| 5486511 |
4-amino-17.beta.-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17.beta.-(cyclopropylamino)androst-4-en-3-one and related compounds as C.sub.17-20 lyase and 5.alpha.-reductase |
Jan. 23, 1996 |
|
|
|
